Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73,039,333
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
43,247,569
-
Shares change
-
-11,335,921
-
Total reported value, excl. options
-
$106,821,389
-
Value change
-
-$553,553,365
-
Put/Call ratio
-
116%
-
Number of buys
-
71
-
Number of sells
-
-93
-
Price
-
$2.47
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q4 2023
190 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43,247,569 shares
of 73,039,333 outstanding shares and own 59% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (4,265,953 shares), BlackRock Inc. (3,814,531 shares), VANGUARD GROUP INC (3,741,925 shares), Capital International Investors (2,354,149 shares), Logos Global Management LP (2,000,000 shares), TANG CAPITAL MANAGEMENT LLC (2,000,000 shares), MILLENNIUM MANAGEMENT LLC (1,934,546 shares), MORGAN STANLEY (1,915,026 shares), GOLDMAN SACHS GROUP INC (1,362,789 shares), and Opaleye Management Inc. (1,140,000 shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.